US Equity
VRTX
— VERTEX PHARMACEUTICALS INCORPORATEDVertex Pharmaceuticals is a biotechnology company focused on developing transformative medicines for cystic fibrosis and other serious diseases.
💰 Market cap: $121.57B📍 50 Northern Avenue, BOSTON, MA, 02210 US🏷️ Pharmaceuticals💵 Previous close: $477.36🔢 7,804 credits left
Add Column
All
Trend
| Date ▾ | Close ▾ |
|---|---|
| 2026-07-24 | $477.36 |
| 2026-07-23 | $473.09 |
| 2026-07-22 | $472.57 |
| 2026-07-21 | $482.00 |
| 2026-07-20 | $480.50 |
| 2026-07-17 | $485.65 |
| 2026-07-16 | $486.03 |
| 2026-07-15 | $477.08 |
| 2026-07-14 | $476.31 |
| 2026-07-13 | $480.25 |
| 2026-07-10 | $485.39 |
| 2026-07-09 | $496.50 |
| 2026-07-08 | $498.43 |
| 2026-07-07 | $522.25 |
| 2026-07-06 | $529.59 |
| 2026-07-02 | $528.04 |
| 2026-07-01 | $498.01 |
| 2026-06-30 | $496.73 |
| 2026-06-29 | $499.65 |
| 2026-06-26 | $491.34 |
| 2026-06-25 | $480.18 |
| 2026-06-24 | $475.20 |
| 2026-06-23 | $468.42 |
| 2026-06-22 | $466.79 |
| 2026-06-18 | $451.63 |
| 2026-06-17 | $458.99 |
| 2026-06-16 | $453.17 |
| 2026-06-15 | $450.46 |
| 2026-06-12 | $444.93 |
| 2026-06-11 | $445.04 |
| 2026-06-10 | $435.71 |
| 2026-06-09 | $445.77 |
| 2026-06-08 | $442.96 |
| 2026-06-05 | $446.83 |
| 2026-06-04 | $441.74 |
| 2026-06-03 | $428.34 |
| 2026-06-02 | $425.09 |
| 2026-06-01 | $438.40 |
| 2026-05-29 | $447.54 |
| 2026-05-28 | $447.97 |
| 2026-05-27 | $437.22 |
| 2026-05-26 | $435.93 |
| 2026-05-22 | $434.52 |
| 2026-05-21 | $433.54 |
| 2026-05-20 | $430.44 |
| 2026-05-19 | $434.31 |
| 2026-05-18 | $436.58 |
| 2026-05-15 | $436.95 |
| 2026-05-14 | $450.41 |
| 2026-05-13 | $453.06 |
| 2026-05-12 | $448.29 |
| 2026-05-11 | $435.17 |
| 2026-05-08 | $429.82 |
| 2026-05-07 | $425.00 |
| 2026-05-06 | $427.65 |
| 2026-05-05 | $424.36 |
| 2026-05-04 | $429.85 |
| 2026-05-01 | $423.92 |
| 2026-04-30 | $427.38 |
| 2026-04-29 | $423.24 |
| 2026-04-28 | $430.14 |